Intrauterine Lidocaine for Laminaria

Completed · Phase 1

Conditions studied: Abortion, Induced, Pain Management

In brief

This is a study to investigate whether instilling a small amount of liquid lidocaine into the uterus will decrease pain felt by women during laminaria insertions done for cervical dilation prior to second trimester abortion. The investigators hypothesize that women who receive intrauterine lidocaine in addition to a paracervical block will experience less pain than women who receive only a paracervical block.

Key facts

Study ID

NCT01541293

Run by

University of North Carolina, Chapel Hill

People needed

72

Starts

2012-09-01

Expected to finish

2013-10-01

Last updated by the study team

2014-05-14

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Can sign informed consent
• Healthy pregnant females
• Weight over 45kg
• Seeking abortion by dilation and evacuation in the second trimester of pregnancy
• Gestational age 14-24 weeks confirmed by clinic ultrasound

You may not qualify if…

• Known allergy or previous reaction to lidocaine, bupivicaine or other anesthetic agent
• Known allergy or previous reaction to ibuprofen or other NSAID

Where it is running

• University of North Carolina, Chapel Hill — Chapel Hill, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.